현재 위치:홈 > 뉴스현황 > Our Events > Medicilon held the P...
저자:medicilon 업로드:2019-01-10 조회수:
Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China.
Medicilon CEO Chun-Lin Chen gave a speech during the seminar where he shared his experience on IND filling for both US and China.
Professor Shuangqing Peng had a topic on New Drug Safety Evaluation Approach.
Dr. Baomin Xin, Medicilon VP of DMPK and BA, shared his experience on big molecule analytical approach and future trend, shifting from Pharma to Biopharma.
Dr. Fei Ma, Executive Director of #DMPK, introduced a new idea of DMPK, including the ideal DMPK research model, DMPK activities during #Drug discovery.
Professor Xiaodong Zhang is #Medicilon VP of #Toxicology.
Dr. Zheyi Hu, Director of Pharmacology, shared his experience on oncology animal models.